mizoribine has been researched along with Disease Models, Animal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Li, W; Lin, X; Liu, Z; Ouyang, W; Wu, Y; Yang, Y; Zhang, X | 1 |
| Iwamura, C; Kameoka, Y; Kobayashi, S; Kusunoki, R; Nagao, T; Nakayama, T; Suzuki, K; Yumura, W | 1 |
| Arakawa, T; Doi, S; Ito, T; Kawai, T; Kohno, N; Masaki, T; Nakashima, A; Takahashi, S; Taniguchi, Y; Yorioka, N | 1 |
| Azuma, N; Matsui, K; Okamura, H; Sano, H; Terada, M; Ueda, H | 1 |
| Kamada, H; Nakagami, K | 1 |
| Goto, M; Kamada, H; Matsuura, S; Nagai, H; Takaoka, Y | 1 |
| Abe, M; Shimizu, M; Shou, I; Tomino, Y; Tsuge, T | 1 |
| Ishikawa, H | 1 |
| Aozuka, S; Chen, XM; Kobayashi, Y | 1 |
1 review(s) available for mizoribine and Disease Models, Animal
| Article | Year |
|---|---|
Mizoribine and mycophenolate mofetil.
Topics: Animals; Arthritis; Carbon-Nitrogen Ligases; Cell Cycle; Cell Division; Clinical Trials as Topic; Creatine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kinetics; Lupus Nephritis; Lymphocytes; Mice; Mitogens; Models, Biological; Models, Chemical; Mycophenolic Acid; Nephrotic Syndrome; Organ Transplantation; Ribonucleosides; Time Factors; Tumor Cells, Cultured | 1999 |
10 other study(ies) available for mizoribine and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
Topics: Administration, Ophthalmic; Animals; Apoptosis; CD4-Positive T-Lymphocytes; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Female; Immunity, Cellular; Immunohistochemistry; Immunosuppressive Agents; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Ribonucleosides; Tears | 2017 |
Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizorib
Topics: Animals; Antibodies; Antibodies, Antineutrophil Cytoplasmic; Chemokine CCL2; Disease Models, Animal; Female; Glomerulonephritis; Humans; Interleukin-6; Mice; Mice, Inbred C57BL; Peroxidase; Receptors, Interleukin-6; Ribonucleosides; T-Lymphocyte Subsets | 2013 |
Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model.
Topics: Actins; Animals; Cell Movement; Chemokine CCL2; Chlorhexidine; Collagen Type III; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fibrosis; Immunosuppressive Agents; Macrophages, Peritoneal; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Ribonucleosides; Transforming Growth Factor beta | 2009 |
Mizoribine protects against bleomycin-induced lung injury.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Count; Cell Proliferation; Disease Models, Animal; Female; Hydroxyproline; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Ribonucleosides; Time Factors | 2010 |
Effect of mizoribine on collagen-induced arthritis in mice.
Topics: Animals; Arthritis; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Immunosuppressive Agents; Male; Mice; Mice, Inbred DBA; Ribonucleosides; Time Factors | 1996 |
Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Arthritis; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Enzyme-Linked Immunosorbent Assay; Female; Hindlimb; Hypersensitivity, Delayed; Immunosuppressive Agents; Indomethacin; Injections, Intradermal; Prednisolone; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Ribonucleosides; Species Specificity; T-Lymphocytes; Tacrolimus | 1997 |
Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice.
Topics: Animals; B-Lymphocytes; Disease Models, Animal; Flow Cytometry; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Immunoglobulin A; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Proteinuria; Ribonucleosides | 1998 |
[Suppressive effect of mizoribine on progression of bovine serum albumin nephritis in mice].
Topics: Animals; Antibody Formation; Antigen-Antibody Complex; Disease Models, Animal; Female; Glomerulonephritis; Immunosuppressive Agents; Mice; Ribonucleosides; Serum Albumin, Bovine | 1987 |